Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised

doi:10.1084/jem.181.6.2221

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Hill, A. B.
	Articles by McMichael, A. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Hill, A. B.
	Articles by McMichael, A. J.


Social Bookmarking

	What's this?

ARTICLES

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised

AB Hill, SP Lee, JS Haurum, N Murray, QY Yao, M Rowe, N Signoret, AB Rickinson and AJ McMichael
Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

We have raised CD8+ cytotoxic T lymphocytes (CTL) from three Epstein- Barr virus-seropositive donors by incubating peripheral blood lymphocytes with irradiated autologous B95.8-strain EBV-transformed B lymphoblastoid cells (LCL). However, to detect lysis in a standard 51Cr release assay of the LCL against which these CTL were raised, superinfection with recombinant vaccinia expressing the appropriate EBV protein or incubation with the peptide epitope was necessary. The untreated LCL were not lysed, even though Western blotting demonstrated that they expressed the EBV antigens containing the CTL epitopes. We have found CTL of this phenotype that are restricted by human leukocyte antigen-A2, -A3, -B7, or -B39, and which recognize the EBV latent proteins, EBV nuclear antigen (EBNA)-3A, EBNA-3C, or terminal protein. During these experiments, we identified a new human leukocyte antigen- A3-restricted EBNA-3A epitope, residues 603-611, RLRAEAGVK. We raised a spontaneous LCL, transformed by endogenous EBV, from one donor, but this was also not lysed. For at least one of the epitopes, CTL from another donor lysed the LCL without superinfection or addition of peptides. We conclude that the CTL were unable to achieve a high enough avidity of interaction with untreated LCL to trigger effector function, although the LCL were able to stimulate them to grow in vitro for up to 4 mo. To assess whether a small percentage of the LCL might possess a higher antigen density, we used an assay of tumor necrosis factor release from a CTL clone, which was able to detect antigen-bearing cells representing only 1% of a stimulating LCL population. Nevertheless, the untreated autologous LCL line failed to stimulate tumor necrosis factor release.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

MacArthur, G. J., Wilson, A. D., Birchall, M. A., Morgan, A. J. (2007). Primary CD4+ T-Cell Responses Provide both Helper and Cytotoxic Functions during Epstein-Barr Virus Infection and Transformation of Fetal Cord Blood B Cells. J. Virol. 81: 4766-4775 [Abstract] [Full Text]
Gandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J., Khanna, R. (2006). Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients. Blood 108: 2280-2289 [Abstract] [Full Text]
Augustinova, H., Hoeller, D., Yao, F. (2004). The Dominant-Negative Herpes Simplex Virus Type 1 (HSV-1) Recombinant CJ83193 Can Serve as an Effective Vaccine against Wild-Type HSV-1 Infection in Mice. J. Virol. 78: 5756-5765 [Abstract] [Full Text]
Lee, S. P., Brooks, J. M., Al-Jarrah, H., Thomas, W. A., Haigh, T. A., Taylor, G. S., Humme, S., Schepers, A., Hammerschmidt, W., Yates, J. L., Rickinson, A. B., Blake, N. W. (2004). CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1. J. Exp. Med. 199: 1409-1420 [Abstract] [Full Text]
Taylor, G. S., Haigh, T. A., Gudgeon, N. H., Phelps, R. J., Lee, S. P., Steven, N. M., Rickinson, A. B. (2004). Dual Stimulation of Epstein-Barr Virus (EBV)-Specific CD4+- and CD8+-T-Cell Responses by a Chimeric Antigen Construct: Potential Therapeutic Vaccine for EBV-Positive Nasopharyngeal Carcinoma. J. Virol. 78: 768-778 [Abstract] [Full Text]
Nikiforow, S., Bottomly, K., Miller, G., Munz, C. (2003). Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation. J. Virol. 77: 12088-12104 [Abstract] [Full Text]
Chakrabarti, S., Milligan, D. W., Pillay, D., Mackinnon, S., Holder, K., Kaur, N., McDonald, D., Fegan, C. D., Waldmann, H., Hale, G., Rickinson, A., Steven, N. (2003). Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. Blood 102: 839-842 [Abstract] [Full Text]
Santodonato, L., D'Agostino, G., Nisini, R., Mariotti, S., Monque, D. M., Spada, M., Lattanzi, L., Paola Perrone, M., Andreotti, M., Belardelli, F., Ferrantini, M. (2003). Monocyte-Derived Dendritic Cells Generated After a Short-Term Culture with IFN-{alpha} and Granulocyte-Macrophage Colony-Stimulating Factor Stimulate a Potent Epstein-Barr Virus-Specific CD8+ T Cell Response. J. Immunol. 170: 5195-5202 [Abstract] [Full Text]
Ong, K.-W., Wilson, A. D., Hirst, T. R., Morgan, A. J. (2003). The B Subunit of Escherichia coli Heat-Labile Enterotoxin Enhances CD8+ Cytotoxic-T-Lymphocyte Killing of Epstein-Barr Virus-Infected Cell Lines. J. Virol. 77: 4298-4305 [Abstract] [Full Text]
Lautscham, G., Haigh, T., Mayrhofer, S., Taylor, G., Croom-Carter, D., Leese, A., Gadola, S., Cerundolo, V., Rickinson, A., Blake, N. (2003). Identification of a TAP-Independent, Immunoproteasome-Dependent CD8+ T-Cell Epitope in Epstein-Barr Virus Latent Membrane Protein 2. J. Virol. 77: 2757-2761 [Abstract] [Full Text]
Kuzushima, K., Hayashi, N., Kudoh, A., Akatsuka, Y., Tsujimura, K., Morishima, Y., Tsurumi, T. (2003). Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells. Blood 101: 1460-1468 [Abstract] [Full Text]
Catalina, M. D., Sullivan, J. L., Bak, K. R., Luzuriaga, K. (2001). Differential Evolution and Stability of Epitope-Specific CD8+ T Cell Responses in EBV Infection. J. Immunol. 167: 4450-4457 [Abstract] [Full Text]
Chapman, A. L. N., Rickinson, A. B., Thomas, W. A., Jarrett, R. F., Crocker, J., Lee, S. P. (2001). Epstein-Barr Virus-specific Cytotoxic T Lymphocyte Responses in the Blood and Tumor Site of Hodgkin's Disease Patients: Implications for a T-cell-based Therapy. Cancer Res. 61: 6219-6226 [Abstract] [Full Text]
Ohlen, C., Kalos, M., Hong, D. J., Shur, A. C., Greenberg, P. D. (2001). Expression of a Tolerizing Tumor Antigen in Peripheral Tissue Does Not Preclude Recovery of High-Affinity CD8+ T Cells or CTL Immunotherapy of Tumors Expressing the Antigen. J. Immunol. 166: 2863-2870 [Abstract] [Full Text]
Gottschalk, S., Ng, C. Y. C., Perez, M., Smith, C. A., Sample, C., Brenner, M. K., Heslop, H. E., Rooney, C. M. (2001). An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. Blood 97: 835-843 [Abstract] [Full Text]
Burrows, S. R., Kienzle, N., Winterhalter, A., Bharadwaj, M., Altman, J. D., Brooks, A. (2000). Peptide-MHC Class I Tetrameric Complexes Display Exquisite Ligand Specificity. J. Immunol. 165: 6229-6234 [Abstract] [Full Text]
Lu, J., Celis, E. (2000). Use of Two Predictive Algorithms of the World Wide Web for the Identification of Tumor-reactive T-Cell Epitopes. Cancer Res. 60: 5223-5227 [Abstract] [Full Text]
Brander, C., Suscovich, T., Lee, Y., Nguyen, P. T., O'Connor, P., Seebach, J., Jones, N. G., van Gorder, M., Walker, B. D., Scadden, D. T. (2000). Impaired CTL Recognition of Cells Latently Infected with Kaposi's Sarcoma-Associated Herpes Virus. J. Immunol. 165: 2077-2083 [Abstract] [Full Text]
Lee, S. P., Chan, A. T. C., Cheung, S.-T., Thomas, W. A., CroomCarter, D., Dawson, C. W., Tsai, C.-H., Leung, S.-F., Johnson, P. J., Huang, D. P. (2000). CTL Control of EBV in Nasopharyngeal Carcinoma (NPC): EBV-Specific CTL Responses in the Blood and Tumors of NPC Patients and the Antigen-Processing Function of the Tumor Cells. J. Immunol. 165: 573-582 [Abstract] [Full Text]
Goulder, P. J. R., Tang, Y., Pelton, S. I., Walker, B. D. (2000). HLA-B57-Restricted Cytotoxic T-Lymphocyte Activity in a Single Infected Subject toward Two Optimal Epitopes, One of Which Is Entirely Contained within the Other. J. Virol. 74: 5291-5299 [Abstract] [Full Text]
Le Borgne, S., Février, M., Callebaut, C., Lee, S. P., Rivière, Y. (2000). CD8+-Cell Antiviral Factor Activity Is Not Restricted to Human Immunodeficiency Virus (HIV)-Specific T Cells and Can Block HIV Replication after Initiation of Reverse Transcription. J. Virol. 74: 4456-4464 [Abstract] [Full Text]
Kuzushima, K., Hoshino, Y., Fujii, K., Yokoyama, N., Fujita, M., Kiyono, T., Kimura, H., Morishima, T., Morishima, Y., Tsurumi, T. (1999). Rapid Determination of Epstein-Barr Virus-Specific CD8+ T-Cell Frequencies by Flow Cytometry. Blood 94: 3094-3100 [Abstract] [Full Text]
Khanna, R., Bell, S., Sherritt, M., Galbraith, A., Burrows, S. R., Rafter, L., Clarke, B., Slaughter, R., Falk, M. C., Douglass, J., Williams, T., Elliott, S. L., Moss, D. J. (1999). Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proc. Natl. Acad. Sci. USA 96: 10391-10396 [Abstract] [Full Text]
Subklewe, M., Chahroudi, A., Schmaljohn, A., Kurilla, M. G., Bhardwaj, N., Steinman, R. M. (1999). Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus. Blood 94: 1372-1381 [Abstract] [Full Text]
Dulphy, N., Peyrat, M.-A., Tieng, V., Douay, C., Rabian, C., Tamouza, R., Laoussadi, S., Berenbaum, F., Chabot, A., Bonneville, M., Charron, D., Toubert, A. (1999). Common Intra-Articular T Cell Expansions in Patients with Reactive Arthritis: Identical {beta}-Chain Junctional Sequences and Cytotoxicity Toward HLA-B27. J. Immunol. 162: 3830-3839 [Abstract] [Full Text]
Munz, C., Obst, R., Osen, W., Stevanovic, S., Rammensee, H.-G. (1999). Alloreactivity as a Source of High Avidity Peptide-Specific Human CTL. J. Immunol. 162: 25-34 [Abstract] [Full Text]
Brooks, J. M., Colbert, R. A., Mear, J. P., Leese, A. M., Rickinson, A. B. (1998). HLA-B27 Subtype Polymorphism and CTL Epitope Choice: Studies with EBV Peptides Link Immunogenicity with Stability of the B27:Peptide Complex. J. Immunol. 161: 5252-5259 [Abstract] [Full Text]
Pepperl, S., Benninger-Doring, G., Modrow, S., Wolf, H., Jilg, W. (1998). Immediate-Early Transactivator Rta of Epstein-Barr Virus (EBV) Shows Multiple Epitopes Recognized by EBV-Specific Cytotoxic T Lymphocytes. J. Virol. 72: 8644-8649 [Abstract] [Full Text]
Kienzle, N., Sculley, T. B., Poulsen, L., Buck, M., Cross, S., Raab-Traub, N., Khanna, R. (1998). Identification of a Cytotoxic T-Lymphocyte Response to the Novel BARF0 Protein of Epstein-Barr Virus: a Critical Role for Antigen Expression. J. Virol. 72: 6614-6620 [Abstract] [Full Text]
Lee, S. P., Constandinou, C. M., Thomas, W. A., Croom-Carter, D., Blake, N. W., Murray, P. G., Crocker, J., Rickinson, A. B. (1998). Antigen Presenting Phenotype of Hodgkin Reed-Sternberg Cells: Analysis of the HLA Class I Processing Pathway and the Effects of Interleukin-10 on Epstein-Barr Virus-Specific Cytotoxic T-Cell Recognition. Blood 92: 1020-1030 [Abstract] [Full Text]
Nazaruk, R. A., Rochford, R., Hobbs, M. V., Cannon, M. J. (1998). Functional Diversity of the CD8+ T-Cell Response to Epstein-Barr Virus (EBV): Implications for the Pathogenesis of EBV-Associated Lymphoproliferative Disorders. Blood 91: 3875-3883 [Abstract] [Full Text]
Steven, N.M., Annels, N.E., Kumar, A., Leese, A.M., Kurilla, M.G., Rickinson, A.B. (1997). Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus-induced Cytotoxic T Cell Response. J. Exp. Med. 185: 1605-1618 [Abstract] [Full Text]